BTAI
Price
$1.35
Change
-$0.04 (-2.88%)
Updated
May 22, 04:52 PM (EDT)
Capitalization
8.42M
SYBX
Price
$1.12
Change
-$0.02 (-1.75%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
13.33M
Interact to see
Advertisement

BTAI vs SYBX

Header iconBTAI vs SYBX Comparison
Open Charts BTAI vs SYBXBanner chart's image
BioXcel Therapeutics
Price$1.35
Change-$0.04 (-2.88%)
Volume$1.74K
Capitalization8.42M
Synlogic
Price$1.12
Change-$0.02 (-1.75%)
VolumeN/A
Capitalization13.33M
BTAI vs SYBX Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. SYBX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a StrongBuy and SYBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (BTAI: $1.39 vs. SYBX: $1.14)
Brand notoriety: BTAI and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 41% vs. SYBX: 58%
Market capitalization -- BTAI: $8.42M vs. SYBX: $13.33M
BTAI [@Biotechnology] is valued at $8.42M. SYBX’s [@Biotechnology] market capitalization is $13.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, SYBX is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 3 TA indicator(s) are bullish while SYBX’s TA Score has 3 bullish TA indicator(s).

  • BTAI’s TA Score: 3 bullish, 4 bearish.
  • SYBX’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, SYBX is a better buy in the short-term than BTAI.

Price Growth

BTAI (@Biotechnology) experienced а +1.46% price change this week, while SYBX (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.83%. For the same industry, the average monthly price growth was +6.69%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

SYBX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+3.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYBX($13.3M) has a higher market cap than BTAI($8.42M). SYBX YTD gains are higher at: -18.571 vs. BTAI (-76.765). BTAI has more cash in the bank: 233M vs. SYBX (18.9M). SYBX has less debt than BTAI: SYBX (0) vs BTAI (105M).
BTAISYBXBTAI / SYBX
Capitalization8.42M13.3M63%
EBITDAN/A-23.01M-
Gain YTD-76.765-18.571413%
P/E RatioN/A5.18-
RevenueN/A8K-
Total Cash233M18.9M1,233%
Total Debt105M0-
FUNDAMENTALS RATINGS
BTAI vs SYBX: Fundamental Ratings
BTAI
SYBX
OUTLOOK RATING
1..100
523
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9662
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BTAI's Valuation (81) in the Biotechnology industry is in the same range as SYBX (86). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

BTAI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SYBX (100). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

SYBX's SMR Rating (98) in the Biotechnology industry is in the same range as BTAI (100). This means that SYBX’s stock grew similarly to BTAI’s over the last 12 months.

SYBX's Price Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for BTAI (96). This means that SYBX’s stock grew somewhat faster than BTAI’s over the last 12 months.

SYBX's P/E Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for BTAI (100). This means that SYBX’s stock grew somewhat faster than BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAISYBX
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 23 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 23 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 23 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 23 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 23 days ago
89%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 28 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X109678.0800002886.992200
+2.70%
Bitcoin cryptocurrency
GME28.05-0.46
-1.61%
GameStop Corp
SPY582.86-9.99
-1.69%
SPDR® S&P 500® ETF
AAPL202.09-4.77
-2.31%
Apple
TSLA334.62-9.20
-2.68%
Tesla

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with TENX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
-2.11%
TENX - BTAI
37%
Loosely correlated
+1.17%
SYBX - BTAI
37%
Loosely correlated
+0.88%
COGT - BTAI
33%
Poorly correlated
-6.21%
SBHMY - BTAI
32%
Poorly correlated
N/A
CRSP - BTAI
31%
Poorly correlated
-5.76%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with SBHMY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then SBHMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
+0.88%
SBHMY - SYBX
39%
Loosely correlated
N/A
BTAI - SYBX
37%
Loosely correlated
-2.11%
ATXS - SYBX
31%
Poorly correlated
-8.62%
SPHRF - SYBX
29%
Poorly correlated
N/A
WHWK - SYBX
28%
Poorly correlated
-3.27%
More